$GILD News Speculators should retain a flexible approach

New Post Public Reply Private Reply Replies (0) Message Board

Dec 10, 2013 at 1:07 PM

$GILD News

Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 4:07 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 3:59 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 7:21 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Best Buy, Gilead Sciences lead S&P 500 gainers 3:05 p.m. Oct. 10, 2013 - Polya Lesova
Gilead, Acura stand out on up day for stocks, Quest tumbles 10:27 a.m. Oct. 10, 2013 - Russ Britt
Gilead ends leukemia study after positive results 4:10 p.m. Oct. 9, 2013 - MarketWatch.com
Citrix, Ruby Tuesday shares fall after hours 4:06 p.m. Oct. 9, 2013 - Wallace Witkowski
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Earnings help McKesson, hospitals; FDA ruling hits Vertex, aids Gilead 9:52 a.m. July 26, 2013 - Russ Britt

Gilead (GILD) Shows Signs Of Being Water-Logged And Getting Wetter 34 min ago - TheStreet.com
Gilead CEO's $21 Million Stock Sale 12:04 p.m. Today - Barrons.com
5 Stocks Underperforming Today In The Drugs Industry 12:04 p.m. Today - TheStreet.com
Geron's Game-Changing Myelofibrosis Drug Story Has a Familiar Feel 11:09 a.m. Today - TheStreet.com
Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD) 9:00 a.m. Today - TheStreet.com
Jakafi competition still a ways off: Canaccord 8:11 a.m. Today - Seeking Alpha
Gilead Sciences: Sovaldi Hepatitis C Pill Approved 6:25 p.m. Dec. 9, 2013 - Seeking Alpha
FDA Clears Gilead's Sovaldi - Analyst Blog 5:00 p.m. Dec. 9, 2013 - Zacks.com
Weekly CEO Sells Highlight: OCZ Technology Group Inc, Workday Inc, Gilead Sciences Inc, Natus ... 4:14 p.m. Dec. 9, 2013 - GuruFocus.com
Today's Market: Deals And News Impacting These Companies 12:59 p.m. Dec. 9, 2013 - Seeking Alpha
Gilead Sciences: A Unique Stallion 11:12 a.m. Dec. 9, 2013 - Seeking Alpha
Celgene, Infinity Rise On Blood Cancer Drug Data 10:24 a.m. Dec. 9, 2013 - Investors Business Daily
Gilead reports data for investigational blood cancer drugs 7:57 a.m. Dec. 9, 2013 - Seeking Alpha
Gilead (GILD) Off To A Strong Start In Pre-Market Activity 7:53 a.m. Dec. 9, 2013 - TheStreet.com
The Numbers Backing Gilead's Best and Fastest Drug Launch in History 6:31 a.m. Dec. 9, 2013 - TheStreet.com
Gilead Announces Phase 2 Study Results for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma at ASH 5:36 p.m. Dec. 8, 2013 - benzinga.com
Gilead Reports Positive Data from Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 7:03 p.m. Dec. 7, 2013 - benzinga.com
FDA Approves Gilead's Hepatitis C Drug 6:53 p.m. Dec. 6, 2013 - WSJ.com
Not Your Father's Diagnostics: Ram Selvaraju On How Molecular Genomics Invigorate The Sector 4:27 p.m. Dec. 6, 2013 - Seeking Alpha
Gilead Potential Blockbuster Hep C Drug Wins FDA Nod 4:22 p.m. Dec. 6, 2013 - Investors Business Daily

Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology 11:00 a.m. Dec. 9, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma 6:00 p.m. Dec. 8, 2013 - BusinessWire
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 6:30 p.m. Dec. 7, 2013 - BusinessWire
U.S. Food and Drug Administration Approves Gilead's Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 4:19 p.m. Dec. 6, 2013 - BusinessWire
Gilead Sciences to Present at the NASDAQ OMX 30th Investor Program on Tuesday, December 3 5:00 p.m. Dec. 2, 2013 - BusinessWire
Critical Alerts For General Electric, Gilead Sciences, Morgan Stanley, Qualcomm, and Adobe Released By InvestorsObserver 9:31 a.m. Dec. 2, 2013 - PR Newswire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire
Gilead Sciences, Inc. Uses the PHT Corporation LogPad(R) System for 1st Antianginal Drug to Treat Type 2 Diabetes 8:00 a.m. Dec. 2, 2013 - BusinessWire
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Early Morning Buzz: Groupon, Gilead Sciences, Eltek Ltd, Alcatel Lucent SA 9:47 a.m. Nov. 27, 2013 - ACCESSWIRE
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Clinical Studies, Convertible Senior Notes, and Commercial Supply Contracts - Research Report on Gilead, Hologic, Regeneron, OPKO, and Unilife 8:00 a.m. Nov. 25, 2013 - PR Newswire
European CHMP Adopts Positive Opinion for Gilead Sciences' Sovaldi(R) for the Treatment of Chronic Hepatitis C Infection 8:47 a.m. Nov. 22, 2013 - BusinessWire
Stock Price Movement, Grants for Projects, and Clinical Data Presentations - Research Report on Gilead, Bristol-Myers Squibb, HCA, Allergan, and Alexion 8:00 a.m. Nov. 20, 2013 - PR Newswire
Gilead's Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study 9:17 a.m. Nov. 18, 2013 - BusinessWire
European Commission Approves Gilead's Vitekta(TM), an Integrase Inhibitor for the Treatment of HIV-1 Infection 8:00 a.m. Nov. 18, 2013 - BusinessWire
Gilead Sciences to Present at the Credit Suisse 2013 Healthcare Conference on Wednesday, November 13 4:31 p.m. Nov. 12, 2013 - BusinessWire
Insider Trading Reports for Facebook, Microsoft, Gilead Sciences, Bank of America, Riverbed, and Wells Fargo 8:55 a.m. Nov. 11, 2013 - PR Newswire
S.F. Voters Repudiate Gilead, Other Pharma's Greed with Prop. D Victory 7:47 p.m. Nov. 7, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Syra Health Joins CMS ACCESS Model for Scalable Growth

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

AWOL Vision's LuxVision: Pushing Home Cinema Limits

AWOL Vision Leaps into the Future at IFA 2026 You'll never look at home entertainment the same way. AWOL Vision's grand entrance at IFA 2026 in Berlin isn't just about a shiny new gadget; it's a full-blown mission to redefine what your living room can do. With its debut of the LuxVision projector, they're not just holding a torch—they're carrying a flamethrower into the...

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Baystate Noble Plans Major ED Expansion for Future Needs

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Finzly Launches AI Security Layer Amid Rising Threats

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

MemoryDriver Relaunches with Navigation Challenge

MemoryDriver's Relight: A Blazing New Course in Brain Health Look at this: Evon Medics is back with a bang, and they're handing us more than just another mind-numbing app update. On September 15, they're flipping the switch on MemoryDriver, their revamped brain-training gig, with a national 'Beat the Clock' Challenge. It’s up for grabs, totally free, and full of...

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Little Sunshine's Opens New School in Peoria, AZ

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...